|
|
Significance of detecting circulating tumor cells in peripheral blood of postoperative patients with non-small cell lung cancer |
DU Kaiqi1,ZHU Youcai1,YANG Yong2,ZHANG Zhihao1,XU Zhuhui1,and LI Xiaofeng1. |
1.Department of Cardiothoracic Surgery, 2.Department of Clinical Iaboratory, Zhejiang Provincial Corps Hospital,Chinese People’s Armed Police Forces, Jiaxing 314000, China |
|
|
Abstract Objective To investigate the significance of detecting circulating tumor cells(CTCs) in peripheral blood of postoperative patients with non-small cell lung cancer(NSCLC). Methods Thirty-eight patients with lung adenocarcinoma diagnosed by pathology and treated by radical surgery, were staged by TNM staging criteria,including stage Ⅰ 19 cases, stage Ⅱ 6 cases, and stage Ⅲ 13 cases. Ten patients with lung benign disease served as control group; they were diagnosed by postoperative pathology(4 cases with tuberculosis, 6 cases with lung inflammatory lesions). CTCs in peripheral blood(every 7.5 ml)were detected by the method of immune magnetic bead-based rare cell enrichment system combined with flow cytometry. Results The positive rate of peripheral blood CTCs was 10%(1/10)in lung benign disease patients and 39.5% (15/38) in NSCLC patients. There was no difference in CTCs positive rate between lung benign disease patients and NSCLC patients(P=0.132).There was difference in CTCs positive rate between Ⅰ stage patients and Ⅲ stage patients(χ2=3.970,P=0.046). Conclusions CTCs can be detected in peripheral blood of postoperative NSCLC patients and can be used to guide the therapy.The positive rate of CTCs is related to TNM staging.
|
Received: 09 October 2013
|
|
|
|
|
[1] |
Okumura Y, Tanaka F, Yoneda K, et al. Circulating tumor cells in pulmonary venous blood of primary lung cancer patients[J]. Ann Thorac Surg, 2009, 87(6): 1669-1675.
|
[2] |
刘志东, 许绍发, 李云松, 等. 非小细胞肺癌循环肿瘤细胞的定量检测[J]. 中华实验外科杂志,2008,25(9): 1130-1131.
|
[3] |
Krebs M G, Sloane R, Priest L, et al. Evaluation and prognostic significance of circulating tumor cells in patients with non-small-cell lung cancer[J]. J Clin Oncol,2011,29(12): 1556-1563.
|
|
|
|